Please log in
You must be logged in to send the contact request.
Manage stand orders
Select Option
BIOTICAL HEALTH, S.L.U.
C/ Sierra De Guadarrama 1 - Edificio Dub,
28830
San Fernando de Henares (Madrid)
Spain
Spain
Submit your contact details
Provide your contact details to the exhibitor. Optionally, you may also add a personal message.
Your name, phone number, and e-mail address are subject to the submission of personal data. Messe Düsseldorf GmbH expressly points out that for a data transmission into third countries, for which no adequacy decision of the EU-commission is on hand certifying an adequate level of protection of personal data, it is not ensured that there are appropriate safeguards for the protection of personal data on hand.
An error has occurred
Please check your internet connection or try again later.
Message has been sent
Your message to the exhibitor was sent successfully.
Contact
Carlos Gonzalez
General Manager
Miguel Ruiz
Technical Manager
David Estrela
Export Area Manager
Visit us
16.11.2020
Topic
all-day
Biotical Health - high quality rapid test, qPCR and biomarkers
Biotical Health is a Spanish laboratory exclusively dedicated to the manufacture, development, and marketing of microbiome-related products, bringing together probiotics and in vitro diagnostic medical devices under a single concept and offering comprehensive expertise for both healthcare professionals and consumers.
Microbiology is the bridge that connects our two business divisions, developed after extensive experience in the pharmaceutical industry and in the diagnostic management of markers and gastrointestinal and respiratory pathogens.
Our diagnostic line includes both high-quality rapid immunochromatographic test, real-time PCR test and biomarkers based in microbiological signatures that deliver quick, simple, and reliable results, making it possible for health professionals to rapidly establish a presumptive diagnosis of infection.
Microbiology is the bridge that connects our two business divisions, developed after extensive experience in the pharmaceutical industry and in the diagnostic management of markers and gastrointestinal and respiratory pathogens.
Our diagnostic line includes both high-quality rapid immunochromatographic test, real-time PCR test and biomarkers based in microbiological signatures that deliver quick, simple, and reliable results, making it possible for health professionals to rapidly establish a presumptive diagnosis of infection.
Our range of products
Product categories
- 03 Diagnostic tests
- 03.02 Immunochemistry testing, immunology testing
- 03.02.02 Diagnostic rapid tests
Diagnostic rapid tests
- 03 Diagnostic tests
- 03.06 Genetic testing, molecular diagnostics
- 03.06.02 Molecular biomarkers
Molecular biomarkers
- 03 Diagnostic tests
- 03.06 Genetic testing, molecular diagnostics
- 03.06.03 Polymerase chain reaction (PCR)
Polymerase chain reaction (PCR)
Our products
Product category: Diagnostic rapid tests
Respiratory pathogens
Antigen-based rapid lateral flow test for a quick, simple, and easy-to-interpret diagnosis, no laboratory equipment required. Results in just 10 minutes.
Biotical Health identifies viral or bacterial air ways infections in urine or nasopharyngeal samples quickly and easily.
Thanks to their easy handling and high sensitivity, Biotical Health’s rapid immunochromatography test qualitatively detects antigens from the most common respiratory pathogens, making possible for the healthcare professional to make a presumptive diagnosis of the infection caused in a very short time.
Each rapid test kit contains, as extra quality control for the validation of the result, a positive control (in the case of nasopharyngeal sample test) or a positive and a negative control (in the case of urine sample test).
Our inactivated dry controls add extra value to the quality of our products.
Biotical Health identifies viral or bacterial air ways infections in urine or nasopharyngeal samples quickly and easily.
Thanks to their easy handling and high sensitivity, Biotical Health’s rapid immunochromatography test qualitatively detects antigens from the most common respiratory pathogens, making possible for the healthcare professional to make a presumptive diagnosis of the infection caused in a very short time.
Each rapid test kit contains, as extra quality control for the validation of the result, a positive control (in the case of nasopharyngeal sample test) or a positive and a negative control (in the case of urine sample test).
Our inactivated dry controls add extra value to the quality of our products.
Product category: Diagnostic rapid tests
Gastrointestinal pathogens
Antigen-based rapid lateral flow test for a quick, simple, and easy-to-interpret diagnosis, no laboratory equipment required. Results in just 10 minutes.
Biotical Health identifies acute gastrointestinal infections caused by viruses, bacteria and parasites, in stool sample quickly and easily.
Thanks to their easy handling and high sensitivity, Biotical Health’s rapid immunochromatography test qualitatively detect antigens of the most common gastrointestinal pathogens, making it possible for the healthcare professional to have a presumptive diagnosis of the infection caused in a very short time.
Biotical Health identifies acute gastrointestinal infections caused by viruses, bacteria and parasites, in stool sample quickly and easily.
Thanks to their easy handling and high sensitivity, Biotical Health’s rapid immunochromatography test qualitatively detect antigens of the most common gastrointestinal pathogens, making it possible for the healthcare professional to have a presumptive diagnosis of the infection caused in a very short time.
Product category: Diagnostic rapid tests
Tumor and inflammatory markers
Biotical Health’s Tumor and Inflammatory Markers line offers qualitative cut-off fecal sample test as indicators of possible inflammatory bowel activity and gastrointestinal bleeding that
are performed quickly and easily, allowing a first non-invasive diagnostic screening of patients.
are performed quickly and easily, allowing a first non-invasive diagnostic screening of patients.
Product category: Diagnostic rapid tests
Positive and Negative controls
NEGATIVE CONTROL
Generic Negative Control (dry and inactivated) valid for all rapid test that allows parallel analysis as extra quality control to reduce the risk of false positive results from contamination during the test procedure.
POSITIVE CONTROLS
Positive Controls available (dry and inactivated) for each of the rapid test that allow to perform a parallel analysis as extra quality control to validate the results of the diagnostic technique.
Generic Negative Control (dry and inactivated) valid for all rapid test that allows parallel analysis as extra quality control to reduce the risk of false positive results from contamination during the test procedure.
POSITIVE CONTROLS
Positive Controls available (dry and inactivated) for each of the rapid test that allow to perform a parallel analysis as extra quality control to validate the results of the diagnostic technique.
Product category: Polymerase chain reaction (PCR)
Real-Time qPCR line: AMPLION REAL-TIME PCR DETECTION KITS
Our AMPLION Real-Time qPCR line includes kits for the quantitative detection of specific regions of genetic material that contain infectious pathogens (respiratory, gastrointestinal, etc.) in human samples.
Highly sensitivity and precise, these test help health professionals accurately check samples for the presence of the pathogen's genetic material.
· Freeze-dried kits. Transportation and storage at room temperature.
· Shelf life: 24 months from manufacture.
· “Ready-to-use” kits: contain all the components required for amplification, including plastic consumables.
· All our kits have the same thermal protocol.
· Easy-to-use. Our freeze-dried master mix comes with everything you need, keeping handling to a minimum and reducing execution time and potential errors.
· Versatile. Analyse anywhere from 1 and 96 different samples.
· Flexible. Most of our kits can be used in the vast majority of open thermal cyclers on the market.
Highly sensitivity and precise, these test help health professionals accurately check samples for the presence of the pathogen's genetic material.
· Freeze-dried kits. Transportation and storage at room temperature.
· Shelf life: 24 months from manufacture.
· “Ready-to-use” kits: contain all the components required for amplification, including plastic consumables.
· All our kits have the same thermal protocol.
· Easy-to-use. Our freeze-dried master mix comes with everything you need, keeping handling to a minimum and reducing execution time and potential errors.
· Versatile. Analyse anywhere from 1 and 96 different samples.
· Flexible. Most of our kits can be used in the vast majority of open thermal cyclers on the market.
Product category: Molecular biomarkers
Biotical Colorectal Cancer Biomarker
biotical CRC Biomarker is a non-invasive test which complements the fecal immunochemical test, reducing the number of unnecessary colonoscopies significantly and enabling early and reliable detection of CRC with the minimum burden for patients.
Scientific evidence:
biotical CRC Biomarker determines the specific bacterial signature of CRC along with the analysis of the fecal immunochemical test. This test has been optimized and validated in several clinical studies performed in reference hospitals, which corroborate that the test has a sensitivity of 98% and a specificity of 92% for CRC, allowing to reduce 30% of unnecessary colonoscopies.
PRODUCT LAUNCH: Q1 2021
Scientific evidence:
biotical CRC Biomarker determines the specific bacterial signature of CRC along with the analysis of the fecal immunochemical test. This test has been optimized and validated in several clinical studies performed in reference hospitals, which corroborate that the test has a sensitivity of 98% and a specificity of 92% for CRC, allowing to reduce 30% of unnecessary colonoscopies.
PRODUCT LAUNCH: Q1 2021
Product category: Molecular biomarkers
biotical IBS Biomarker
Irritable bowel syndrome is a chronic intestinal disease that runs with abdominal pain associated with diarrhea and/or
constipation. It affects 11% of the population, and it is amongst the top 10 most difficult diseases since the diagnostic can take between 1 to 5 years. At present, the diagnostic consists of performing a wide variety of invasive procedures such as colonoscopy.
biotical IBS Biomarker determines the presence in the stool of a specific bacterial signature of Irritable Bowel Syndrome. This test has been clinically validated in collaboration with referent hospitals. The test is carried out under a quality system certified by ISO13485 necessary for diagnostic products.
PRODUCT LAUNCH: Q1 2021
constipation. It affects 11% of the population, and it is amongst the top 10 most difficult diseases since the diagnostic can take between 1 to 5 years. At present, the diagnostic consists of performing a wide variety of invasive procedures such as colonoscopy.
biotical IBS Biomarker determines the presence in the stool of a specific bacterial signature of Irritable Bowel Syndrome. This test has been clinically validated in collaboration with referent hospitals. The test is carried out under a quality system certified by ISO13485 necessary for diagnostic products.
PRODUCT LAUNCH: Q1 2021
Product category: Molecular biomarkers
biotical IBD Biomarker
biotical IBD Biomarker is a new non-invasive test to monitor the status of the intestinal mucosa in patients with Inflammatory Bowel Disease (IBD), showing a significant correlation with endoscopic activity. The capacity of the test to determine activity in patients with Chron’s disease and ulcerative colitis has demonstrated to outperform the current non-invasive tests, having the
capability to reduce the number of colonoscopies to perform for the follow-up of the disease.
biotical IBD Biomarker is based on the detection of a bacterial signature specific to the disease. The test has been clinically validated in collaboration with different referent hospitals.
The test is carried out under a quality system certified by ISO13485, necessary for diagnostic products.
PRODUCT LAUNCH: Q1 2021
capability to reduce the number of colonoscopies to perform for the follow-up of the disease.
biotical IBD Biomarker is based on the detection of a bacterial signature specific to the disease. The test has been clinically validated in collaboration with different referent hospitals.
The test is carried out under a quality system certified by ISO13485, necessary for diagnostic products.
PRODUCT LAUNCH: Q1 2021
About us
Company details
Biotical Health is a Spanish laboratory exclusively dedicated to the manufacture, development, and marketing of microbiome-related products, bringing together probiotics and in vitro diagnostic medical devices under a single concept and offering comprehensive expertise for both healthcare professionals and consumers.
Company data
Export contentmax. 50%
Area of businessDiagnostics